AAAAAA
Results:
1-18
|
Results: 18
Authors:
McMurray, RW
Citation: Rw. Mcmurray, Estrogen, prolactin, and autoimmunity: actions and interactions, INT IMMUNO, 1(6), 2001, pp. 995-1008
Authors:
Jenkins, JK
Suwannaroj, S
Elbourne, KB
Ndebele, K
McMurray, RW
Citation: Jk. Jenkins et al., 17-beta-estradiol alters Jurkat lymphocyte cell cycling and induces apoptosis through suppression of Bcl-2 and cyclin A, INT IMMUNO, 1(11), 2001, pp. 1897-1911
Authors:
McMurray, RW
Keisler, D
Kanuckel, K
Izui, S
Walker, SE
Citation: Rw. Mcmurray et al., Modulation of hormones in the treatment of lupus (vol 7, pg 487, 2001), AM J M CARE, 7(11), 2001, pp. 1030-1030
Authors:
McMurray, RW
Ndebele, K
Hardy, KJ
Jenkins, JK
Citation: Rw. Mcmurray et al., 17-beta-estradiol suppresses IL-2 and IL-2 receptor, CYTOKINE, 14(6), 2001, pp. 324-333
Authors:
McMurray, RW
Suwannaroj, S
Ndebele, K
Jenkins, JK
Citation: Rw. Mcmurray et al., Differential effects of sex steroids on T and B cells: Modulation of cell cycle phase distribution, apoptosis and bcl-2 protein levels, PATHOBIOLOG, 69(1), 2001, pp. 44-58
Authors:
Suwannaroj, S
Lagoo, A
McMurray, RW
Citation: S. Suwannaroj et al., Suppression of renal disease and mortality in the female NZB x NZW F-1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid, LUPUS, 10(8), 2001, pp. 562-567
Authors:
Suwannaroj, S
Lagoo, A
Keisler, D
McMurray, RW
Citation: S. Suwannaroj et al., Antioxidants suppress mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE), LUPUS, 10(4), 2001, pp. 258-265
Authors:
Shatley, MJ
Walker, BL
McMurray, RW
Citation: Mj. Shatley et al., Lues and lupus: syphilis mimicking systemic lupus erythematosus (SLE), LUPUS, 10(4), 2001, pp. 299-303
Authors:
McMurray, RW
Citation: Rw. Mcmurray, Prolactin in murine systemic lupus erythematosus, LUPUS, 10(10), 2001, pp. 742-747
Authors:
McMurray, RW
Citation: Rw. Mcmurray, Bromocriptine in rheumatic and autoimmune diseases, SEM ARTH RH, 31(1), 2001, pp. 21-32
Authors:
McMurray, RW
Citation: Rw. Mcmurray, Nonstandard and adjunctive medical therapies for systemic lupus erythematosus, ARTH RH ART, 45(1), 2001, pp. 86-100
Authors:
Thongngarm, T
McMurray, RW
Citation: T. Thongngarm et Rw. Mcmurray, Primary psoas abscess, ANN RHEUM D, 60(2), 2001, pp. 173-174
Authors:
Thongngarm, T
McMurray, RW
Citation: T. Thongngarm et Rw. Mcmurray, Osteoarthritis of the Sternoclavicular joint, JCR-J CLIN, 6(5), 2000, pp. 269-271
Authors:
Walker, SE
Smarr, KL
Parker, JC
Weidensaul, DN
Nelson, W
McMurray, RW
Citation: Se. Walker et al., Mood states and disease activity in patients with systemic lupus erythematosus treated with bromocriptine, LUPUS, 9(7), 2000, pp. 527-533
Authors:
Thongngarm, T
Lynch, C
McMurray, RW
Citation: T. Thongngarm et al., Primary non-Hodgkin's lymphoma of bone, J RHEUMATOL, 27(12), 2000, pp. 2932-2934
Authors:
McMurray, RW
Wilson, JG
Bigler, L
Xiang, LB
Lagoo, A
Citation: Rw. Mcmurray et al., Progesterone inhibits glucocorticoid-induced murine thymocyte apoptosis, INT J IMMUN, 22(11), 2000, pp. 955-965
Authors:
Suwannaroj, S
Elkins, SL
McMurray, RW
Citation: S. Suwannaroj et al., Systemic lupus erythematosus and Castleman's disease, J RHEUMATOL, 26(6), 1999, pp. 1400-1403
Authors:
McMurray, RW
Elbourne, KB
Lagoo, A
Lal, S
Citation: Rw. Mcmurray et al., Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus, J RHEUMATOL, 25(12), 1998, pp. 2364-2370
Risultati:
1-18
|